Physician profile
Francesca Cottini
NPI 1447646773
$9,186.87
in general payments reported to CMS, 2019-2025
8 companies · $489 in 2025
The $489 reported for 2025 was less than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.22 · 2023: $135 · 2024: $8,545 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,606 · Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,606.00 |
| Food and Beverage | $563.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $8,572.15 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $300.00 | 2024-2025 | Talvey |
| Janssen Biotech, INC. | $224.76 | 2023-2024 | Darzalex |
| Astrazeneca Uk Limited | $72.74 | 2025 | |
| Janssen Research & Development, LLC | $17.22 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francesca Cottini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.